 |
|
Effect of tibolone on the survival of early stage cervical adenocarcinoma patients
Seung-Ho Lee, Yoon-Jin Cho, Kyung-Joo Cho, Mee-Hyang Ko, Sun-Young Jung, Seung-Joo Chon, So-Yi Lim, Kwang-Beom Lee
Obstet Gynecol Sci. 2018;61(5):584-589. Published online 2018 Aug 7 DOI: https://doi.org/10.5468/ogs.2018.61.5.584
|
|
Citations to this article as recorded by
 Hormone Replacement Therapy in Post-Menopause Hormone-Dependent Gynecological Cancer Patients: A Narrative Review
Paola Villa, Valentina Elisabetta Bounous, Inbal Dona Amar, Federica Bernardini, Margherita Giorgi, Daniela Attianese, Annamaria Ferrero, Marika D’Oria, Giovanni Scambia
Journal of Clinical Medicine.2024; 13(5): 1443. CrossRef Safety of hormone replacement therapy in women with a history of cervical adenocarcinoma
A Richardson, L Watson, M Persic, A Phillips
Post Reproductive Health.2021; 27(3): 167. CrossRef Hormone replacement therapy following treatment of gynaecological malignancies
Alison Richardson, Julie Ayres, Mike Cust, Andrew Phillips
The Obstetrician & Gynaecologist.2019; 21(4): 291. CrossRef
|